Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

[Blastic plasmacytoid dendritic cell neoplasm with complete clinical remission with chemotherapy and central nervous system relapse: Report of one case].

Contreras L, Mercado L, Delgado C, Cabezas C, Starke L, Romero M, Ibieta F, Henríquez M, Chandia M.

Rev Med Chil. 2017 Jan;145(1):115-120. doi: 10.4067/S0034-98872017000100015. Spanish.

2.

Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia.

Vidriales MB, Pérez-López E, Pegenaute C, Castellanos M, Pérez JJ, Chandía M, Díaz-Mediavilla J, Rayón C, de Las Heras N, Fernández-Abellán P, Cabezudo M, de Coca AG, Alonso JM, Olivier C, Hernández-Rivas JM, Montesinos P, Fernández R, García-Suárez J, García M, Sayas MJ, Paiva B, González M, Orfao A, San Miguel JF; PETHEMA Programa para el Estudio de la Terapéutica en Hemopatías Malignas Cooperative Study Group.

Leuk Res. 2016 Jan;40:1-9. doi: 10.1016/j.leukres.2015.10.002. Epub 2015 Oct 22.

PMID:
26598032
3.

[Bone marrow microenvironment in chronic myeloid leukemia: implications for disease physiopathology and response to treatment].

Aristizábal JA, Chandia M, Del Cañizo MC, Sánchez-Guijo F.

Rev Med Chil. 2014 May;142(5):599-605. doi: 10.4067/S0034-98872014000500008. Review. Spanish.

4.

The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma.

Paiva B, Chandia M, Puig N, Vidriales MB, Perez JJ, Lopez-Corral L, Ocio EM, Garcia-Sanz R, Gutierrez NC, Jimenez-Ubieto A, Lahuerta JJ, Mateos MV, San Miguel JF.

Haematologica. 2015 Feb;100(2):e53-5. doi: 10.3324/haematol.2014.115162. Epub 2014 Nov 7. No abstract available.

5.

[Sustained hematologic response in chronic eosinophilic leukemia with low dose imatinib. Report of one case].

Torres C D, Chandía M.

Rev Med Chil. 2014 Apr;142(4):516-20. doi: 10.4067/S0034-98872014000400015. Spanish.

6.

Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma.

Paiva B, Chandia M, Vidriales MB, Colado E, Caballero-Velázquez T, Escalante F, Garcia de Coca A, Montes MC, Garcia-Sanz R, Ocio EM, Mateos MV, San Miguel JF.

Blood. 2014 Aug 21;124(8):1300-3. doi: 10.1182/blood-2014-04-567909. Epub 2014 May 29.

7.

Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene.

Chandia M, Sayagués JM, Gutiérrez ML, Chillón ML, Aristizábal JA, Corrales A, Castellanos M, Melón A, Sánchez ML, Bárcena P, Matarraz S, González-González M, Barrena S, López A, Cañizo MC, Sánchez-Guijo F, Orfao A.

Am J Hematol. 2014 Mar;89(3):288-94.

8.

The relationship between suicide and Islam: a cross-national study.

Shah A, Chandia M.

J Inj Violence Res. 2010 Jun;2(2):93-7. doi: 10.5249/jivr.v2i2.60.

9.

Protection against in vivo liver ischemia-reperfusion injury by n-3 long-chain polyunsaturated fatty acids in the rat.

Zúñiga J, Venegas F, Villarreal M, Núñez D, Chandía M, Valenzuela R, Tapia G, Varela P, Videla LA, Fernández V.

Free Radic Res. 2010 Aug;44(8):854-63. doi: 10.3109/10715762.2010.485995.

PMID:
20528561
10.

[POEMS syndrome with an isolated lytic lesion and glomeruloid hemangiomas: report of one case].

Chandía M, Salomone C, Bertín P, González S.

Rev Med Chil. 2009 May;137(5):680-4. doi: /S0034-98872009000500013. Epub 2009 Jul 17. Spanish.

11.

Synthesis, characterization and biodistribution of bisphosphonates Sm-153 complexes: correlation with molecular modeling interaction studies.

Neves M, Gano L, Pereira N, Costa MC, Costa MR, Chandia M, Rosado M, Fausto R.

Nucl Med Biol. 2002 Apr;29(3):329-38.

PMID:
11929703
12.

[Nationally produced 153SmEDTMP in the palliative treatment of metastatic bone cancer pain].

Olea E, Gil MC, Tomicic M, Araya G, Chandía M, Quintana JC, Pinto L, Orellana P, Nagel J, Ortíz V.

Rev Med Chil. 1996 Jul;124(7):805-12. Spanish.

PMID:
9138368

Supplemental Content

Loading ...
Support Center